Achaogen, Inc. was a big mover last session, as its shares rose almost 18% on the day. The upside was driven by a rating upgrade of the company. This also led to far more shares changing hands than in a normal session. Yesterday’s rally continues the recent uptrend for the company, as the stock is now up nearly 66% in the past one-month time frame.

Over the last 30 days, the company witnessed two positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Achaogen currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

A better-ranked med-drugs stock is Juniper Pharmaceuticals, Inc. , sporting a Zacks Rank #1 (Strong Buy).

Is AKAO going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>